2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$1.20+$0.03 (+3.00%)
Price as of Nov 20, 2026 7:30 PM EST- $239.7MMarket Cap
- 137.76%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$1.20+$0.03 (+3.00%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.17 | ||
Change | -$0.15 (-11.74%) | ||
Open | $1.32 | ||
High | $1.32 | ||
Low | $1.16 | ||
Previous Close | $1.32 | ||
Volume | 916,612 | ||
30-Day Average Volume | 951,600 | ||
1-Week Change | -29.39% | ||
1-Month Change | -28.96% | ||
1-Year Change | 137.76% | ||
3-Year Change | -18.53% | ||
5-Year Change | -94.35% | ||
Fundamentals | |||
Shares Outstanding | 181.6M | ||
Total Assets | $262.6M | ||
Market Cap | $239.7M | ||
Enterprise Value | $194.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.5M | ||
Free Cash Flow | -$22.8M | ||
EBIT | -$23.5M | ||
EBITDA | -$21.3M | ||
Net Working Capital | $108.7M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue